Loading…
Reported covered position: Legislative Correspondent and Legislative Assistant for Senator Johnny Isakson
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: VIATRIS INC · Firm: VIATRIS INC.
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2026 · first_quarter · Q1
S.2296 National Defense Authorization Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
Source: Senate LDA
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
Increasing Transparency in Generic Drug Applications Act
Client: VIATRIS INC · Firm: VIATRIS INC.
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
IP Issues related to generic medicines Patent Settlements S 1553, The PREVAIL Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
National Defense Authorization Act for Fiscal Year 2026
Client: VIATRIS INC · Firm: VIATRIS INC.
S.2296 National Defense Authorization Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
Trade issues related to generic medicines Pharmaceutical supply chain S.3778: Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act S.3841: Last Sale Valuation Act
Trade issues related to generic medicines Pharmaceutical supply chain S.3778: Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act S.3841: Last Sale Valuation Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: VIATRIS INC · Firm: VIATRIS INC.
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: VIATRIS INC · Firm: VIATRIS INC.
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages The Medication Affordability and Patent Integrity Act
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: VIATRIS INC · Firm: VIATRIS INC.
Part D Formulary Design and Generic Drug Tiering S. 1302 - Increasing Transparency in Generic Drug Applications Act H.R. 1843 - Increasing Transparency in Generic Drug Applications Act S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503/S. 2916, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages S. 891, the Bipartisan Health Care Act
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: VIATRIS INC · Firm: VIATRIS INC.
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages The Medication Affordability and Patent Integrity Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
HR 9747 Countinuing Appropriations and Extensions Act of 2025 (Title II, all provisions relating to Health Extenders)
HR 9747 Countinuing Appropriations and Extensions Act of 2025 (Title II, all provisions relating to Health Extenders)
HR 9747 Countinuing Appropriations and Extensions Act of 2025 (Title II, all provisions relating to Health Extenders)
HR 9747 Countinuing Appropriations and Extensions Act of 2025 (Title II, all provisions relating to Health Extenders)
Increasing Transparency in Generic Drug Applications Act
Client: VIATRIS INC · Firm: VIATRIS INC.
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
Increasing Transparency in Generic Drug Applications Act
Client: VIATRIS INC · Firm: VIATRIS INC.
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages The Medication Affordability and Patent Integrity Act
Increasing Transparency in Generic Drug Applications Act
Client: VIATRIS INC · Firm: VIATRIS INC.
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
Increasing Transparency in Generic Drug Applications Act
Client: VIATRIS INC · Firm: VIATRIS INC.
Part D Formulary Design and Generic Drug Tiering S. 1302 - Increasing Transparency in Generic Drug Applications Act H.R. 1843 - Increasing Transparency in Generic Drug Applications Act S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503/S. 2916, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages S. 891, the Bipartisan Health Care Act
IP Issues related to generic medicines Patent Settlements S 1553, The PREVAIL Act
IP Issues related to generic medicines Patent Settlements S 1553, The PREVAIL Act
IP Issues related to generic medicines Patent Settlements S 1553, The PREVAIL Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages The Medication Affordability and Patent Integrity Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
National Defense Authorization Act for Fiscal Year 2026
Client: VIATRIS INC · Firm: VIATRIS INC.
S.2296 National Defense Authorization Act
National Defense Authorization Act for Fiscal Year 2026
Client: VIATRIS INC · Firm: VIATRIS INC.
S.2296 National Defense Authorization Act
National Defense Authorization Act for Fiscal Year 2026
Client: VIATRIS INC · Firm: VIATRIS INC.
S.2296 National Defense Authorization Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
S4638 2025 National Defense Authorization Act
Part D Formulary Design and Generic Drug Tiering S. 1302 - Increasing Transparency in Generic Drug Applications Act H.R. 1843 - Increasing Transparency in Generic Drug Applications Act S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503/S. 2916, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages S. 891, the Bipartisan Health Care Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages The Medication Affordability and Patent Integrity Act
Part D Formulary Design and Generic Drug Tiering S. 1302 - Increasing Transparency in Generic Drug Applications Act H.R. 1843 - Increasing Transparency in Generic Drug Applications Act S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503/S. 2916, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages S. 891, the Bipartisan Health Care Act
Ensuring Access to Lower-Cost Medicines for Seniors Act of 2023
Client: VIATRIS INC · Firm: VIATRIS INC.
Part D Formulary Design and Generic Drug Tiering S. 1302 - Increasing Transparency in Generic Drug Applications Act H.R. 1843 - Increasing Transparency in Generic Drug Applications Act S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503/S. 2916, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages S. 891, the Bipartisan Health Care Act
Ensuring Access to Lower-Cost Medicines for Seniors Act
Client: VIATRIS INC · Firm: VIATRIS INC.
Part D Formulary Design and Generic Drug Tiering S. 1302 - Increasing Transparency in Generic Drug Applications Act H.R. 1843 - Increasing Transparency in Generic Drug Applications Act S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503/S. 2916, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages S. 891, the Bipartisan Health Care Act
IP Issues related to generic medicines Patent Settlements S 2220, The PREVAIL Act
Part D Formulary Design and Generic Drug Tiering S. 1302 - Increasing Transparency in Generic Drug Applications Act H.R. 1843 - Increasing Transparency in Generic Drug Applications Act S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503/S. 2916, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages S. 891, the Bipartisan Health Care Act
Increasing Transparency in Generic Drug Applications Act
Client: VIATRIS INC · Firm: VIATRIS INC.
Part D Formulary Design and Generic Drug Tiering S. 1302 - Increasing Transparency in Generic Drug Applications Act H.R. 1843 - Increasing Transparency in Generic Drug Applications Act S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503/S. 2916, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages S. 891, the Bipartisan Health Care Act
HR 9747 - Continuing Appropriations and Extensions Act of 2025 (Title II, all provisions relating to Health Extenders)
IP Issues related to patient access to medicines Patent Settlements S 2220, The PREVAIL Act
IP Issues related to patient access to medicines Patent Settlements S 2220, The PREVAIL Act
National Defense Authorization Act for Fiscal Year 2025
Client: VIATRIS INC · Firm: VIATRIS INC.
S. 4638 - 2025 National Defense Authorization Act
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
Otto Warmbier Countering North Korean Censorship and Surveillance Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
Otto Warmbier Countering North Korean Censorship and Surveillance Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
Otto Warmbier Countering North Korean Censorship and Surveillance Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
Otto Warmbier Countering North Korean Censorship and Surveillance Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
COVID–19 Vaccine Dishonorable Discharge Prevention Act
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
COVID–19 Vaccine Dishonorable Discharge Prevention Act
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
IP Issues related to generic medicines Patent Settlements S.2780: Medication Affordability and Patient Integrity Act (U.S. Senate) H.R. 5429: Medication Affordability and Patient Integrity Act (U.S. House)
IP Issues related to generic medicines Patent Settlements S.2780: Medication Affordability and Patient Integrity Act (U.S. Senate) H.R. 5429: Medication Affordability and Patient Integrity Act (U.S. House)
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 4338 - Increasing Transparency in Generic Drug Applications Act, (S. 775); from the 117th Congress HR1503, Prescription Information Modernization Act Implementation of the Inflation Reduction Act Presidents Emergency Plan for AIDS Relief Reauthorization
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Presidents Emergency Plan for AIDS Relief Reauthorization
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Presidents Emergency Plan for AIDS Relief Reauthorization
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 4338 - Increasing Transparency in Generic Drug Applications Act, (S. 775); from the 117th Congress HR1503, Prescription Information Modernization Act Implementation of the Inflation Reduction Act Presidents Emergency Plan for AIDS Relief Reauthorization
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
Otto Warmbier Countering North Korean Censorship and Surveillance Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act
Otto Warmbier Countering North Korean Censorship and Surveillance Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
Increasing Transparency in Generic Drug Applications Act
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 4338 - Increasing Transparency in Generic Drug Applications Act, (S. 775); from the 117th Congress HR1503, Prescription Information Modernization Act Implementation of the Inflation Reduction Act Presidents Emergency Plan for AIDS Relief Reauthorization
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Presidents Emergency Plan for AIDS Relief Reauthorization
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 4338 - Increasing Transparency in Generic Drug Applications Act, (S. 775); from the 117th Congress HR1503, Prescription Information Modernization Act Implementation of the Inflation Reduction Act Presidents Emergency Plan for AIDS Relief Reauthorization
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act
H.R. 3 - Lower Drug Costs Now Act; H.R. 2846 - Ensuring Access to Lower-Cost Medicines for Seniors Act; H.R. 5376 - the Inflation Reduction Act of 2022; S. 4348 - the Food and Drug Administration Safety and Landmark Advancements Act of 2022; Biosimilar interchangeability ; Part D Formulary Design and Generic Drug Tiering; H.R. 7667 - the Food and Drug Amendments of 2022; H.R. 8239 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2023, and for other purposes; S. 4338 - the Increasing Transparency in Generic Drug Applications Act S. 4351 - the Enhanced Access to Affordable Medicines Act H.R. 7559 - the Prescription Information Modernization Act of 2022; H.R. 2617 - Consolidated Appropriations Act of 2023
Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 3 - Lower Drug Costs Now Act; H.R. 2846 - Ensuring Access to Lower-Cost Medicines for Seniors Act; H.R. 5376 - the Inflation Reduction Act of 2022; S. 4348 - the Food and Drug Administration Safety and Landmark Advancements Act of 2022; Biosimilar interchangeability ; Part D Formulary Design and Generic Drug Tiering; H.R. 7667 - the Food and Drug Amendments of 2022; H.R. 8239 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2023, and for other purposes; S. 4338 - the Increasing Transparency in Generic Drug Applications Act S. 4351 - the Enhanced Access to Affordable Medicines Act H.R. 7559 - the Prescription Information Modernization Act of 2022; H.R. 2617 - Consolidated Appropriations Act of 2023
Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 3 - Lower Drug Costs Now Act; Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs H.R. 2846 - Ensuring Access to Lower-Cost Medicines for Seniors Act; Generic drug quality and FDA oversight H.R. 5376 - the Inflation Reduction Act of 2022; S. 4348 - the Food and Drug Administration Safety and Landmark Advancements Act of 2022 Biosimilar interchangeability Part D Formulary Design and Generic Drug Tiering; Electronic labeling of prescription drugs H.R. 7667 - the Food and Drug Amendments of 2022; H.R. 8239 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2023, and for other purposes; FDA facility inspections S. 4338 - the Increasing Transparency in Generic Drug Applications Act S. 4351 - the Enhanced Access to Affordable Medicines Act H.R. 7559 - the Prescription Information Modernization Act of 2022; Complex Generic Drug Approvals
Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 3 - Lower Drug Costs Now Act; Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs H.R. 2846 - Ensuring Access to Lower-Cost Medicines for Seniors Act; Generic drug quality and FDA oversight H.R. 5376 - Build Back Better Act; Part D Formulary Design and Generic Drug Tiering S. 4348 - the Food and Drug Administration Safety and Landmark Advancements Act of 2022 Biosimilar interchangeability Part D Formulary Design and Generic Drug Tiering; Electronic labeling of prescription drugs H.R. 7667 - the Food and Drug Amendments of 2022; H.R. 8239 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2023, and for other purposes. FDA facility inspections Medicate incentives for biosimilar utilization Complex Generic Drug Approvals
Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs Generic drug quality and FDA oversight Part D Formulary Design and Generic Drug Tiering Electronic Labeling of Prescription Drugs FDA facility inspections Medicare incentives for biosimilar utilization Generic Drug User Fee Amendments (GDUFA) Complex Generic Drug Approvals H.R. 3 - Lower Drug Costs Now Act H.R. 2846 - Ensuring Access to Lower-Cost Medicines for Seniors Act Biosimilar interchangeability H.R. 5376 - Build Back Better Act H.R. 6973, Enhanced Access to Affordable Medicines Act of 2022 H.R. 7032, Increasing Transparency in Generic Drug Applications Act of 2022
H.R. 3 - Lower Drug Costs Now Act; H.R. 2846 - Ensuring Access to Lower-Cost Medicines for Seniors Act; H.R. 5376 - the Inflation Reduction Act of 2022; S. 4348 - the Food and Drug Administration Safety and Landmark Advancements Act of 2022; Biosimilar interchangeability ; Part D Formulary Design and Generic Drug Tiering; H.R. 7667 - the Food and Drug Amendments of 2022; H.R. 8239 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2023, and for other purposes; S. 4338 - the Increasing Transparency in Generic Drug Applications Act S. 4351 - the Enhanced Access to Affordable Medicines Act H.R. 7559 - the Prescription Information Modernization Act of 2022; H.R. 2617 - Consolidated Appropriations Act of 2023
IP Issues related to generic medicines Patent Settlements S 1553, The PREVAIL Act
Trade issues related to generic medicines Pharmaceutical supply chain S.3778: Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act S.3841: Last Sale Valuation Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
2025 · fourth_quarter · Q4
S.2296 National Defense Authorization Act
HR 9747 Countinuing Appropriations and Extensions Act of 2025 (Title II, all provisions relating to Health Extenders)
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
IP Issues related to generic medicines Patent Settlements S 1553, The PREVAIL Act
Trade issues related to generic medicines Pharmaceutical supply chain
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
2025 · third_quarter · Q3
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
IP Issues related to generic medicines Patent Settlements S 1553, The PREVAIL Act
Trade issues related to generic medicines Pharmaceutical supply chain
S.2296 National Defense Authorization Act
HR 9747 Countinuing Appropriations and Extensions Act of 2025 (Title II, all provisions relating to Health Extenders)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
2025 · second_quarter · Q2
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages The Medication Affordability and Patent Integrity Act
IP Issues related to generic medicines Patent Settlements S 1553, The PREVAIL Act
Trade issues related to generic medicines Pharmaceutical supply chain
S.2296 National Defense Authorization Act
HR 9747 Countinuing Appropriations and Extensions Act of 2025 (Title II, all provisions relating to Health Extenders)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
2025 · first_quarter · Q1
Part D Formulary Design and Generic Drug Tiering S. 1302 - Increasing Transparency in Generic Drug Applications Act H.R. 1843 - Increasing Transparency in Generic Drug Applications Act S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503/S. 2916, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages S. 891, the Bipartisan Health Care Act
IP Issues related to generic medicines Patent Settlements S 2220, The PREVAIL Act
Trade issues related to generic medicines Pharmaceutical supply chain
S4638 2025 National Defense Authorization Act
HR 9747 Countinuing Appropriations and Extensions Act of 2025 (Title II, all provisions relating to Health Extenders)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Q4
HR 9747 - Continuing Appropriations and Extensions Act of 2025 (Title II, all provisions relating to Health Extenders)
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
2024 · third_quarter · Q3
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
Trade issues related to generic medicines Pharmaceutical supply chain
2024 · second_quarter · Q2
Trade issues related to generic medicines Pharmaceutical supply chain
IP Issues related to patient access to medicines Patent Settlements
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
2024 · first_quarter · Q1
IP Issues related to generic medicines Patent Settlements
Trade issues related to generic medicines Pharmaceutical supply chain
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
2023 · fourth_quarter · Q4
IP Issues related to generic medicines Patent Settlements
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
2023 · third_quarter · Q3
IP Issues related to generic medicines Patent Settlements S.2780: Medication Affordability and Patient Integrity Act (U.S. Senate) H.R. 5429: Medication Affordability and Patient Integrity Act (U.S. House)
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act
2023 · second_quarter · Q2
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Presidents Emergency Plan for AIDS Relief Reauthorization
Trade issues related to generic medicines Pharmaceutical supply chain
IP Issues related to generic medicines Patent Settlements
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Q1
Trade issues related to generic medicines Pharmaceutical supply chain
Corporate Tax Policy
Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs Patent Settlements
2022 · fourth_quarter · Q4
Trade issues related to generic medicines Pharmaceutical supply chain
VA Access to affordable medicines
Corporate Tax Policy
2022 · third_quarter · Q3
Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs Patent Settlements S4417 - Patent Trial and Appeal Board (PTAB) Reform Act of 2022
Trade issues related to generic medicines Pharmaceutical supply chain
H.R. 3 - Lower Drug Costs Now Act; Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs H.R. 2846 - Ensuring Access to Lower-Cost Medicines for Seniors Act; Generic drug quality and FDA oversight H.R. 5376 - the Inflation Reduction Act of 2022; S. 4348 - the Food and Drug Administration Safety and Landmark Advancements Act of 2022 Biosimilar interchangeability Part D Formulary Design and Generic Drug Tiering; Electronic labeling of prescription drugs H.R. 7667 - the Food and Drug Amendments of 2022; H.R. 8239 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2023, and for other purposes; FDA facility inspections S. 4338 - the Increasing Transparency in Generic Drug Applications Act S. 4351 - the Enhanced Access to Affordable Medicines Act H.R. 7559 - the Prescription Information Modernization Act of 2022; Complex Generic Drug Approvals
2022 · second_quarter · Q2
Medicaid Rebate provision of the Bipartisan Budget Act of 2015
Corporate Tax Policy
H.R. 3 - Lower Drug Costs Now Act; Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs H.R. 2846 - Ensuring Access to Lower-Cost Medicines for Seniors Act; Generic drug quality and FDA oversight H.R. 5376 - Build Back Better Act; Part D Formulary Design and Generic Drug Tiering S. 4348 - the Food and Drug Administration Safety and Landmark Advancements Act of 2022 Biosimilar interchangeability Part D Formulary Design and Generic Drug Tiering; Electronic labeling of prescription drugs H.R. 7667 - the Food and Drug Amendments of 2022; H.R. 8239 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2023, and for other purposes. FDA facility inspections Medicate incentives for biosimilar utilization Complex Generic Drug Approvals
2022 · first_quarter · Q1
Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs Generic drug quality and FDA oversight Part D Formulary Design and Generic Drug Tiering Electronic Labeling of Prescription Drugs FDA facility inspections Medicare incentives for biosimilar utilization Generic Drug User Fee Amendments (GDUFA) Complex Generic Drug Approvals H.R. 3 - Lower Drug Costs Now Act H.R. 2846 - Ensuring Access to Lower-Cost Medicines for Seniors Act Biosimilar interchangeability H.R. 5376 - Build Back Better Act H.R. 6973, Enhanced Access to Affordable Medicines Act of 2022 H.R. 7032, Increasing Transparency in Generic Drug Applications Act of 2022
Trade issues related to generic medicines Pharmaceutical supply chain
Trade issues related to generic medicines Pharmaceutical supply chain
S. 4638 - 2025 National Defense Authorization Act
IP Issues related to patient access to medicines Patent Settlements S 2220, The PREVAIL Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
IP Issues related to patient access to medicines Patent Settlements S 2220, The PREVAIL Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Trade issues related to generic medicines Pharmaceutical supply chain
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Trade issues related to generic medicines Pharmaceutical supply chain
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 4338 - Increasing Transparency in Generic Drug Applications Act, (S. 775); from the 117th Congress HR1503, Prescription Information Modernization Act Implementation of the Inflation Reduction Act Presidents Emergency Plan for AIDS Relief Reauthorization
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
H.R. 3 - Lower Drug Costs Now Act; H.R. 2846 - Ensuring Access to Lower-Cost Medicines for Seniors Act; H.R. 5376 - the Inflation Reduction Act of 2022; S. 4348 - the Food and Drug Administration Safety and Landmark Advancements Act of 2022; Biosimilar interchangeability ; Part D Formulary Design and Generic Drug Tiering; H.R. 7667 - the Food and Drug Amendments of 2022; H.R. 8239 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2023, and for other purposes; S. 4338 - the Increasing Transparency in Generic Drug Applications Act S. 4351 - the Enhanced Access to Affordable Medicines Act H.R. 7559 - the Prescription Information Modernization Act of 2022; H.R. 2617 - Consolidated Appropriations Act of 2023
Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs Patent Settlements
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Corporate Tax Policy
VA Access to affordable medicines
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs Patent Settlements S4417 - Patent Trial and Appeal Board (PTAB) Reform Act of 2022
Trade issues related to generic medicines Pharmaceutical supply chain
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Medicaid Rebate provision of the Bipartisan Budget Act of 2015
Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs Patent Settlements
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE